HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SP-303 small-particle aerosol treatment of influenza A virus infection in mice and respiratory syncytial virus infection in cotton rats.

Abstract
A natural plant product, SP-303, was administered by small-particle aerosol to influenza A/HK virus-infected mice and RSV-infected cotton rats. Aqueous SP-303 at 2 mg/ml in the Collison nebulizer reservoir generated an aerosol with an output of 26 micrograms/l and a particle size distribution of 1.4 microns +/- 4.6 (MMAD +/- GSD). SP-303 at a dosage of 0.5-9.4 mg/kg per day administered for 3-4 days significantly increased both the rate and duration of survival of mice lethally infected with influenza A/HK virus. SP-303 was toxic to mice at 16 mg/kg per day as indicated by weight loss and a decrease in the duration of survival compared to control animals. From these data, a maximum therapeutic index (T.I.) of 12 was calculated. SP-303 given 3-4 days at dosages of 1.3-9.8 mg/kg per day was effective in reducing the pulmonary titer of RSV in infected cotton rats. However, at the 18.7 mg/kg per day dose a significant weight loss compared to control animals was observed; a T.I. of < or = 14 was estimated. These experiments demonstrate that aerosol administration of SP-303 was effective in the treatment of influenza A-infected mice and of RSV-infected cotton rats.
AuthorsB E Gilbert, P R Wyde, S Z Wilson, L R Meyerson
JournalAntiviral research (Antiviral Res) Vol. 21 Issue 1 Pg. 37-45 (May 1993) ISSN: 0166-3542 [Print] Netherlands
PMID8317921 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Aerosols
  • Antiviral Agents
  • Biopolymers
  • Plant Extracts
  • Catechin
  • crofelemer
Topics
  • Administration, Inhalation
  • Aerosols
  • Animals
  • Antiviral Agents (pharmacokinetics, pharmacology)
  • Biopolymers
  • Catechin (analogs & derivatives, pharmacokinetics, pharmacology)
  • Dose-Response Relationship, Drug
  • Humans
  • Influenza A virus
  • Influenza, Human (drug therapy, microbiology)
  • Mice
  • Mice, Inbred ICR
  • Plant Extracts (pharmacology)
  • Rats
  • Respiratory Syncytial Viruses
  • Respirovirus Infections (drug therapy, microbiology)
  • Therapeutic Equivalency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: